Evaluate’s latest analysis forecasts an $82 billion increase in major product revenues in 2025 – the largest annual growth ...

Nearly every disease has an inflammatory component, but blood tests can't pinpoint inflammation in specific organs or tissues ...

A review of recent trends and remaining challenges in bispecific antibody (bsAb) production has been published.

New kits are designed to offer a convenient method to label any antibody with one of Bio-Rad’s StarBright Dyes.

AI for accelerated antibody discovery Traditionally, mAbs are initially discovered (hit identification, or HI) through experimental techniques, like hybridoma screening or high throughput ...

A UK study finds detectable antibodies reduce COVID-19 infection and severity in immunosuppressed individuals, highlighting ...

AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

Immunoglobulin G (IgG) antibodies are a critical component of the adaptive immune system, binding to and neutralizing pathogens and other foreign substances. Recent advances in molecular antibody ...

The integration of artificial intelligence (AI) into drug discovery is reshaping the pharmaceutical landscape. Generative chemistry, leveraging deep learning models, offers unprecedented capabilities ...